AI assistant
Arkema — Capital/Financing Update 2014
Oct 24, 2014
1117_iss_2014-10-24_98d556f6-ecc7-4c27-92a5-a032602f55b3.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
Colombes, 24th October 2014
Arkema issues perpetual hybrid bonds for €700 million
Arkema has successfully completed the first stage of the financing of its proposed acquisition* of Bostik, a major adhesives player, with the issuance of perpetual hybrid bonds for €700 million.
The bonds will include a first call on October 29, 2020 and will carry an annual coupon of 4.75 % until that date. The coupon will then be reset every 5 years.
The issuance has seen strong investor interest, with an order book above €2 billion.
The bonds will be subordinated to any senior debt, and will be recognized in equity in accordance with IFRS rules. They will be subject to capital treatment equivalent to 50% of their amount by Moody's and Standard and Poor's rating agencies.
* Project subject to the legal information and consultation procedure involving the work councils of Arkema, Bostik and Total, as well as to the approval of the relevant antitrust authorities in the countries concerned.
A global chemical company and France's leading chemicals producer, Arkema is building the future of the chemical industry every day. Deploying a responsible, innovation-based approach, we produce state-of-the-art specialty chemicals that provide customers with practical solutions to such challenges as climate change, access to drinking water, the future of energy, fossil fuel preservation and the need for lighter materials. With operations in more than 40 countries, some 14,000 employees and 10 research centers, Arkema generates annual revenue of some €6.1 billion, and holds leadership positions in all its markets with a portfolio of internationally recognized brands.
This announcement does not constitute an offer to sell, or a solicitation of offers to purchase or subscribe for, securities in the United States of America. The securities referred to herein have not been, and will not be, registered under the US Securities Act of 1933, and may not be offered or sold in the United States of America absent registration or an applicable exemption from registration requirements. This notice is issued pursuant to Rule 135c of the US Securities Act of 1933.
Investor Relations contact
| Sophie Fouillat | Tél. +33 1 49 00 86 37 | [email protected] |
|---|---|---|
| François Ruas | Tél. +33 1 49 00 72 07 | [email protected] |
| Press contact | ||
Véronique Obrecht Tél. +33 1 49 00 88 41 [email protected]